NCT00181532View on ClinicalTrials.gov

Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC

PHASE2CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

January 31, 2008

Conditions

Non Small Cell Lung Carcinoma

Interventions

DRUG

Celecoxib

Trial Locations (1)

6411 PC

Maastircht Radiation Oncology, Heerlen

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Maastricht Radiation Oncology

OTHER